$RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is RXRX down today? It is at $3.34 (-4.57%), and our scanner flagged it 287 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RXRX spikes, and full due diligence on RXRX — key stats, earnings, dilution and insider activity. Free.
Get free $RXRX alerts the moment volume spikes
Our scanner flagged $RXRX 287 times in the last 30 days. Create a free account to track $RXRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $3.34
- Change today
- -4.57%
- Previous close
- $3.50
- 52-week range
- $2.77 – $7.18
- Market cap
- $1.79B
- Institutional own.
- 78.98%
- Total held
- 79.0%
- Tradeable float
- 112.7M 21% of shares · after 79% institutions
- Short interest
- 180.8M ▲ +0% vs prior · as of 2026-07-31
- Days to cover
- 9.3d
- Avg daily volume
- 24.7M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 6.6x
- 15m
- 3.1x
- 1h
- 1.7x
- 1D
- 0.9x
Get free RXRX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $RXRX down today?
RXRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 16 unusual-volume and momentum alerts on RXRX today, peaking at 179.7x its normal volume.
Analyst data via Nasdaq. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
Insiders
11 buys, 12 sells last 3 months (40/61 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Taylor Ben R Officer | Sold (automatic/other) | -25K | sold 2.3% | 1.08M | $79K at $3.16 | Aug 17, 26 |
Hallett David Officer | Sold (automatic/other) | -27K | sold 2.5% | 1.04M | $84K at $3.16 | Aug 17, 26 |
Khan Najat Officer | Sold (automatic/other) | -80K 0.02% of company | sold 3.7% | 2.10M | $254K at $3.16 | Aug 17, 26 |
Borgeson Blake Director | Sold (automatic/other) | -30K | sold 0.5% | 6.19M | $98K at $3.25 | Aug 4, 26 |
Borgeson Blake Director | Sold (automatic/other) | -40K | sold 0.6% | 6.22M | $158K at $3.96 | Jul 7, 26 |
Li Dean Y Director | Acquired (grant/award) | +4K | added 0.3% | 1.47M | n/a | Jul 1, 26 |
Dar Zavain Director | Acquired (grant/award) | +5K | added 2.2% | 241K | n/a | Jul 1, 26 |
Bumpus Namandje Director | Sold (automatic/other) | -4K | sold 3.0% | 128K | $13K at $3.18 | Jun 18, 26 |
Li Dean Y Director | Acquired (grant/award) | +88K 0.02% of company | added 6.4% | 1.47M | n/a | Jun 17, 26 |
Bumpus Namandje Director | Acquired (grant/award) | +88K 0.02% of company | added 100% | 132K | n/a | Jun 17, 26 |
Dar Zavain Director | Acquired (grant/award) | +88K 0.02% of company | added 60% | 236K | n/a | Jun 17, 26 |
Sun Elaine D Director | Acquired (grant/award) | +88K 0.02% of company | added 100% | 136K | n/a | Jun 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $RXRX. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$RXRX Sentiment
BearishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$RXRX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to RXRX
Comparable names in biological products, (no diagnostic substances), closest in size first.
RXRX stock FAQ
Why is $RXRX down today?
RXRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 16 unusual-volume and momentum alerts on RXRX today, peaking at 179.7x its normal volume.
What is the RXRX stock price today?
RXRX last traded at $3.34, down 4.57% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live RXRX alerts?
The RXRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RXRX 287 times in the last 30 days.
What exchange is RXRX on?
RXRX (Recursion Pharmaceuticals, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $1.79B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is RXRX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RXRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.